Abstract
Background
Emulsified isoflurane was designed to circumvent the deficiencies of inhalation anesthetics, which have a longer time to onset, result in a higher drug consumption, and for which a specific anesthesia machine is required for clinical use. The aim of this study was to compare the efficacy and safety of emulsified isoflurane with propofol for anesthesia induction in adults patients.
Methods
This multicenter, randomized, double-blind, positive-controlled, non-inferiority, phase III clinical trial compared the efficacy and safety of emulsified isoflurane with propofol for anesthesia induction. Each patient in the emulsified isoflurane group received a single bolus injection of 12% emulsified isoflurane at a dose of 30 mg/kg, and each patient in the propofol group received a single bolus injection of 0.8% propofol at a dose of 2 mg/kg. The primary outcome of the efficacy evaluation was the proportion of participants with successful anesthesia induction, which was regarded as a Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) score of < 1 and lack of use of other sedative drugs. A number of secondary efficacy outcomes were also assessed. Safety was monitored based on (1) adverse events, (2) repeated measurement of vital signs; (3) physical examination, (4) routine laboratory examinations of hematology, biochemistry, urine, coagulation function, and (5) 12-lead electrocardiogram.
Results
A total of 416 patients were enrolled (n = 208 in each group) and 398 patients were administered study drug. The proportion of participants with successful anesthesia induction was 100% with a 95% confidence interval of − 1.9% to + 1.9% for the emulsified isoflurane and propofol groups, which met the predesigned non-inferiority criteria of 5%. The study demonstrated the non-inferiority of sedation produced by emulsified isoflurane compared to propofol. Among the secondary efficacy outcomes, emulsified isoflurane showed a better cardiovascular stability than propofol. The number of patients from the emulsified isoflurane group who experienced drug-related adverse events was significantly higher than that of patients from the propofol group. However, there was no significant difference between the two groups in terms of adverse events or drug-related adverse events of grades 3–5.
Conclusions
Emulsified isoflurane exhibited non-inferiority of anesthesia/sedation compared to propofol in patients undergoing anesthesia induction.
Clinical Trial Registration
ChiCTR2000038185, registered on 12 December, 2020 (www.chictr.org.cn).
Similar content being viewed by others
References
Kopriva CJ, Lowenstein E. An anesthetic accident: cardiovascular collapse from liquid halothane delivery. Anesthesiology. 1969;30(2):246–7.
Sandison JW, Sivapragasam S, Hayes JA, Woo-Ming MO. An experimental study of pulmonary damage associated with intravenous injection of halothane in dogs. Br J Anaesth. 1970;42(5):419–24.
Sutton J, Harrison GA, Hickie JB. Accidental intravenous injection of halothane: case report. Br J Anaesth. 1971;43(5):513–20.
Kawamoto M, Suzuki N, Takasaki M. Acute pulmonary edema after intravenous liquid halothane in dogs. Anesth Analg. 1992;74(5):747–52.
Biber B, Johannesson G, Lennander O, Martner J, Sonander H, Werner O. Intravenous infusion of halothane dissolved in fat: haemodynamic effects in dogs. Acta Anaesthesiol Scand. 1984;28(4):385–9.
Johannesson G, Alm P, Biber B, Lennander O, Werner O. Halothane dissolved in fat as an intravenous anaesthetic to rats. Acta Anaesthesiol Scand. 1984;28(4):381–4.
Huang H, Zhang W, Liu S, Yanfang C, Li T, Liu J. Cardioprotection afforded by St Thomas solution is enhanced by emulsified isoflurane in an isolated heart ischemia reperfusion injury model in rats. J Cardiothorac Vasc Anesth. 2010;24(1):99–103.
Zhou C, Wu W, Liu J, Liao DQ, Kang Y, Chen XD. Inhibition of voltage-gated sodium channels by emulsified isoflurane may contribute to its subarachnoid anesthetic effect in beagle dogs. Reg Anesth Pain Med. 2011;36(6):553–9.
Huang H, Zhou C, Liu J, Song H, Qiu Y. Adding emulsified isoflurane to cardioplegia solution produces cardiac protection in a dog cardiopulmonary bypass model. Sci Rep. 2016;28(6):23572.
Yang XL, Ma HX, Yang ZB, Liu AJ, Luo NF, Zhang WS, et al. Comparison of minimum alveolar concentration between intravenous isoflurane lipid emulsion and inhaled isoflurane in dogs. Anesthesiology. 2006;104(3):482–7.
Zhou JX, Luo NF, Liang XM, Liu J. The efficacy and safety of intravenous emulsified isoflurane in rats. Anesth Analg. 2006;102(1):129–34.
Zhou C, Liu J. A novel intravenous general anesthetic–emulsified isoflurane: from bench to bedside. Front Med. 2012;6(4):381–7.
Huang H, Li R, Liu J, Zhang W, Liao T, Yi X. A phase I, dose-escalation trial evaluating the safety and efficacy of emulsified isoflurane in healthy human volunteers. Anesthesiology. 2014;120(3):614–25.
Doyle DJ, Goyal A, Bansal P, Garmon EH. American Society of Anesthesiologists classification. Treasure Island: StatPearls; 2020.
Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and reliability of the Observer’s Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244–51.
Fast JP, Perkins MG, Pearce RA, Mecozzi S. Fluoropolymer-based emulsions for the intravenous delivery of sevoflurane. Anesthesiology. 2008;109(4):651–6.
Yang H, Yin Q, Huang L, Zhang M, Zhang X, Sun Q, et al. The bioequivalence of emulsified isoflurane with a new formulation of emulsion: a single-center, single-dose, double-blinded, randomized, two-period crossover study. Front Pharmacol. 2021;12: 626307.
Jiajun ZHU, Jindong LIU, Daliang W, Yongwan W, Hailong XU. Effect of isoflurane treatment on myocardial ischemia-reperfusion injury of rats. J Clin Med Pract. 2016;17:4–7.
Tsikas D, Jordan J, Engeli S. Blood pressure-lowering effects of propofol or sevoflurane anaesthesia are not due to enhanced nitric oxide formation or bioavailability. Br J Clin Pharmacol. 2015;79(6):1030–3.
Sneyd JR, Absalom AR, Barends CRM, Jones JB. Hypotension during propofol sedation for colonoscopy: an exploratory analysis. Br J Anaesth. 2021;128(4):610–22.
Hilton P, Dev VJ, Major E. Intravenous anaesthesia with propofol and alfentanil: the influence of age and weight. Anaesthesia. 1986;41(6):640–3.
Ebert TJ, Muzi M, Berens R, Goff D, Kampine JP. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology. 1992;76(5):725–33.
Tan CH, Onsiong MK. Pain on injection of propofol. Anaesthesia. 1998;53(5):468–76.
Doenicke AW, Roizen MF, Hoernecke R, Lorenz W, Ostwald P. Solvent for etomidate may cause pain and adverse effects. Br J Anaesth. 1999;83(3):464–6.
Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, et al. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ. 2011;15(342): d1110.
Liu X, Nakano M, Yamaguchi A, Bush B, Akiyoshi K, Lee JK, et al. The association of bispectral index values and metrics of cerebral perfusion during cardiopulmonary bypass. J Clin Anesth. 2021;74: 110395.
Sieber FE, Zakriya KJ, Gottschalk A, Blute MR, Lee HB, Rosenberg PB, et al. Sedation depth during spinal anesthesia and the development of postoperative delirium in elderly patients undergoing hip fracture repair. Mayo Clin Proc. 2010;85(1):18–26.
Radtke FM, Franck M, Lendner J, Kruger S, Wernecke KD, Spies CD. Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Br J Anaesth. 2013;110(Suppl. 1):i98-105.
Chan MT, Cheng BC, Lee TM, Gin T, Group CT. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013;25(1):33–42.
Wildes TS, Mickle AM, Ben Abdallah A, Maybrier HR, Oberhaus J, Budelier TP, et al. Effect of electroencephalography-guided anesthetic administration on postoperative delirium among older adults undergoing major surgery: the ENGAGES randomized clinical trial. JAMA. 2019;321(5):473–83.
Sieber FE, Neufeld KJ, Gottschalk A, Bigelow GE, Oh ES, Rosenberg PB, et al. Effect of depth of sedation in older patients undergoing hip fracture repair on postoperative delirium: the STRIDE randomized clinical trial. JAMA Surg. 2018;153(11):987–95.
Short TG, Campbell D, Frampton C, Chan MTV, Myles PS, Corcoran TB, et al. Anaesthetic depth and complications after major surgery: an international, randomised controlled trial. Lancet. 2019;394(10212):1907–14.
Morohashi T, Itakura S, Shimokawa KI, Ishii F, Ikeda T, Kazama T. The effectiveness and stability of a 20% emulsified sevoflurane formulation for intravenous use in rats. Anesth Analg. 2016;122(3):712–8.
Morohashi T, Itakura S, Shimokawa KI, Ishii F, Sanjo Y, Kazama T. Anesthetic potency of intravenous infusion of 20% emulsified sevoflurane and effect on the blood-gas partition coefficient in dogs. Anesth Analg. 2021;132(2):575–83.
Karlsen KL, Persson E, Wennberg E, Stenqvist O. Anaesthesia, recovery and postoperative nausea and vomiting after breast surgery: a comparison between desflurane, sevoflurane and isoflurane anaesthesia. Acta Anaesthesiol Scand. 2000;44(4):489–93.
Valanne JV, Korttila K. Recovery following general anesthesia with isoflurane or enflurane for outpatient dentistry and oral surgery. Anesth Prog. 1988;35(2):48–52.
Chiari PC, Pagel PS, Tanaka K, Krolikowski JG, Ludwig LM, Trillo RA Jr, et al. Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits. Anesthesiology. 2004;101(5):1160–6.
Liu S-l, Liu J. Cadioprotective effects of emulsified isoflurane and intralipid on ischemia-reperfusion injury in isolated rat heart. West China J Pharm Sci. 2007;22(5):525.
Hu Q, Wang J, Chang X, Long C. Cardioprotective effects of emulsified isoflurane strengthened cardioplegia on ischemia-reperfusion injury in isolated rat hearts. J Clin Med Pract. 2009;13:5–8.
Liu SL, Liu J. Apoptosis mechanism of intralipid postconditioning to reduce ischemia reperfusion injury of islated rat hearts. Sichuan da Xue Xue Bao Yi Xue Ban. 2007;38(4):663–6.
Yan R, Wang YL, Chen YQ, Zhang WS, Liu J. Protective effects of emulsified isoflurane after myocardial ischemia-reperfusion injury and its mechanism in rabbits. Chin J Traumatol. 2009;12(1):18–21.
Yang MC, Chen YP, Cao DJ, Qian XU. The optimal concentration for the protective effect of emulsified isoflurane on the neonatal rat cardiac myocytes hypoxia/reoxygenation injury of primary culture. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009;40(6):1075–7.
Tan X, Chen Y, Zhang W, Liu J. Effect of emulsified isoflurane on myocardial apoptosis and expressions of and induced by hypoxia-reoxygenation. Acta Acad Med Mil Tert. 2008;30(17):1611–4.
Xing-Qin T, Yu-Pei C. Emulsified isoflurane protects hypoxia/reoxgenation injury in cultured neonatal rat myocardial cells by suppressing caspase-3 expression. Acta Academiae Medicinae Mil Tert. 2009;31(14):1341–4.
Hu ZY, Luo NF, Liu J. The protective effects of emulsified isoflurane on myocardial ischemia and reperfusion injury in rats. Can J Anaesth. 2009;56(2):115–25.
Yang Z, Wu S, Zhao J, Wang Z, Yao M, Lu P, et al. Emulsified isoflurane protects beta cells against high glucose-induced apoptosis via inhibiting endoplasmic reticulum stress. Ann Palliat Med. 2020;9(1):90–7.
Acknowledgments
The authors sincerely thank all participants in the clinical studies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The study received funding from Humanwell Healthcare (Group) Co., Ltd.
Conflicts of Interest/Competing Interests
No sources of funding were received for the conduct of this study or the preparation of this article.
Ethics Approval
The study was approved by the ethics committee of each participating hospital.
Consent to Participate
Informed consent was obtained from all individual participants included in the study.
Consent for Publication
Not applicable.
Availability of Data and Material
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code Availability
Not applicable.
Authors’ Contributions
HY and YJZ wrote the manuscript; HY YJZ, JL, and WSZ designed the research; HY, CLL, YWO, YHZ, YX, GFZ, YSL, CC, GHX, KMY, and QW performed the research; HY, YJZ, JL, and WSZ analyzed the data; MZ and LEL funded the study; and WSZ revised the manuscript.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yang, H., Zhang, Y., Liu, C. et al. A Multicenter, Randomized, Double-Blind, Positive-Controlled, Non-Inferiority, Phase III Clinical Trial Evaluating the Efficacy and Safety of Emulsified Isoflurane for Anesthesia Induction in Patients. CNS Drugs 36, 1301–1311 (2022). https://doi.org/10.1007/s40263-022-00970-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40263-022-00970-w